[3H]tyramine binding: a comparison with neuronal [3H]dopamine uptake and [3H]mazindol binding processes

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Dopamine (DA) receptors and transporters are crucial for neurotransmission.
• Differentiating between DA receptor subtypes and transporter binding sites is essential for understanding DAergic system function.
• The role of thyroid hormones in regulating DAergic pathways is not fully elucidated.

Purpose of the Study:

• To investigate the chemico-physical properties of [3H]Spiperone ([3H]SPI) and [3H]tyramine ([3H]PTA) binding sites.
• To determine if [3H]PTA binding sites are associated with DA receptors or transporters.
• To assess the impact of neonatal hypothyroidism on [3H]PTA and [3H]mazindol ([3H]MAZ) binding and DA uptake.

Main Methods:

• Solubilization of [3H]SPI binding sites from rat and bovine striata using CHAPS and digitonin detergents.
• Characterization of binding properties of solubilized sites.
• In vivo and in vitro binding assays using [3H]PTA, [3H]DA, and [3H]MAZ in membrane preparations from euthyroid and hypothyroid rats.
• Assessment of reserpine's effect on [3H]PTA and [3H]MAZ binding.

Main Results:

• Solubilized [3H]SPI sites retained native binding characteristics.
• [3H]PTA binding sites were distinct from DA receptors and were significantly decreased in hypothyroid rats.
• [3H]DA uptake and [3H]PTA binding were reduced in hypothyroidism, while [3H]MAZ binding remained unaffected.
• Reserpine inhibited [3H]PTA binding but not [3H]MAZ binding.

Conclusions:

• [3H]PTA binding sites are strongly associated with the vesicular transporter for dopamine (DA), not DA receptors.
• [3H]MAZ labels a site involved in neuronal membrane DA translocation, which is less sensitive to thyroid hypofunction.
• Neonatal hypothyroidism impairs intracellular DA storage, as indicated by reduced [3H]PTA binding.
• [3H]PTA can serve as a marker for the DA vesicular transporter.